Insider · CIK 0001273885
Franklin M Berger
Files at AVIR (Atea Pharmaceuticals, Inc.), EPIX (ESSA Pharma Inc.), KZR (Kezar Life Sciences, Inc.), RTSN (Retension Pharmaceuticals, Inc.). First filing Dec 12, 2024, latest Jan 17, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AVIR: Atea Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 27Weak | AVIRbuy Atea Pharmaceuticals, Inc. | $81k 25,000 shares | +6% | - | |
| 50Moderate | AVIRsell Atea Pharmaceuticals, Inc. | $1.0M 359,606 shares | -44% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | RTSN Retension Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +5,636 | $0.00 | $0 | 5,636 | 4 d ago |
| Oct 9, 2025 | EPIX ESSA Pharma Inc. | DDisposition to issuer Common Shares | -784,404 | - | - | 0 | Oct 15, 2025 |
| Jun 20, 2025 | AVIR Atea Pharmaceuticals, Inc. | MOption exercise Common Stock | +29,600 | $0.00 | $0 | 506,497 | Jun 24, 2025 |
| Jun 20, 2025 | AVIR Atea Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +29,600 | $0.00 | $0 | 29,600 | Jun 24, 2025 |
| Jun 20, 2025 | AVIR Atea Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +41,200 | $0.00 | $0 | 41,200 | Jun 24, 2025 |
| Jun 20, 2025 | AVIR Atea Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -29,600 | $0.00 | $0 | 0 | Jun 24, 2025 |
| Jun 18, 2025 | KZR Kezar Life Sciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +5,000 | $0.00 | $0 | 5,000 | Jun 23, 2025 |
| Jan 15, 2025 | AVIR Atea Pharmaceuticals, Inc. | POpen-market purchase Common Stock | -15,000 | $3.19 | $48k | 466,897 | Jan 17, 2025 |
| Jan 16, 2025 | AVIR Atea Pharmaceuticals, Inc. | POpen-market purchase Common Stock | -10,000 | $3.36 | $34k | 476,897 | Jan 17, 2025 |
| Dec 10, 2024 | AVIR Atea Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -359,606 | $2.85 | $1.0M | 451,897 | Dec 12, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.